| Non-alcoholic fatty liver disease (NAFLD)–pathogenesis, classification, and effect on drug metabolizing enzymes and transporters E Cobbina, F Akhlaghi Drug metabolism reviews 49 (2), 197-211, 2017 | 666 | 2017 |
| The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study L Mary R, T Jenica D, G Mwlod, S Melanie L, D Alexandra A, L April N, ... Molecular Psychiatry, 2018 | 114* | 2018 |
| Evaluation of the binding of oxovanadium(IV) to human serum albumin I Correia, T Jakusch, E Cobbinna, S Mehtab, I Tomaz, NV Nagy, ... Dalton Transactions 41 (21), 6477-6487, 2012 | 84 | 2012 |
| Binding of oxovanadium (IV) complexes to blood serum albumins E Cobbina, S Mehtab, I Correia, G Gonçalves, I Tomaz, I Cavaco, ... Journal of the Mexican Chemical Society 57 (3), 180-191, 2013 | 28 | 2013 |
| Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers MR Lee, M Farokhnia, E Cobbina, A Saravanakumar, X Li, JT Battista, ... Neuropharmacology 170, 107788, 2020 | 26 | 2020 |
| Neuroendocrine response to exogenous ghrelin administration, combined with alcohol, in heavy-drinking individuals: findings from a randomized, double-blind, placebo-controlled … M Farokhnia, KM Abshire, A Hammer, SL Deschaine, A Saravanakumar, ... International Journal of Neuropsychopharmacology 24 (6), 464-476, 2021 | 13 | 2021 |
| A population pharmacokinetic analysis of PF-5190457, a novel ghrelin receptor inverse agonist in healthy volunteers and in heavy alcohol drinkers E Cobbina, MR Lee, L Leggio, F Akhlaghi Clinical pharmacokinetics 60, 471-484, 2021 | 10 | 2021 |
| A systems pharmacology model for gene therapy in sickle cell disease B Zheng, L Wille, K Peppel, D Hagen, A Matteson, J Ahlers, J Schaff, ... CPT: Pharmacometrics & Systems Pharmacology 10 (7), 696-708, 2021 | 7 | 2021 |
| The current status and future of medical laboratory quality regulation and accreditation in Ghana E Cobbina, JY Agbezudor, PS Amuzu, TK Gyampomah Accreditation and quality assurance 17, 613-619, 2012 | 6 | 2012 |
| Quantitative association analyses of CNS safety pharmacology parameters to clinical observations in toxicology studies JK DaSilva, E Cobbina, C Tyszkiewicz, D Li, S Goody Journal of Pharmacological and Toxicological Methods 99, 106595, 2019 | 1 | 2019 |
| Hepatic lipid accumulation in experimental heparg model for steatosis influences bupropion biotransformation A Saravanakumar, E Cobbina, X Bush, F Akhlaghi Drug Metabolism and Pharmacokinetics 33 (1), S30-S31, 2018 | 1 | 2018 |
| Population pharmacokinetics of trastuzumab deruxtecan (T-DXd) in subjects with HER2-mutant and HER2-overexpressing non-small cell lung cancer (NSCLC). A Khatri, E Cobbina, S Cheng, M Abutarif, T Garimella Journal of Clinical Oncology 42 (16_suppl), e20537-e20537, 2024 | | 2024 |
| Exposure-response (ER) analyses of efficacy and safety of trastuzumab deruxtecan (T-DXd) to inform dosing recommendation in HER2-mutant non-small cell lung … A Khatri, D Polhamus, E Cobbina, R Garcia, T Yoder, M Abutarif, ... Journal of Clinical Oncology 42 (16_suppl), e20545-e20545, 2024 | | 2024 |
| CHARACTERIZATION OF NEUTROPHIL DYNAMICS IN HIV PATIENTS RECEIVING BUSULFAN E Cobbina, O Wolstein, M Tortorici, J Roberts, T Yuraszeck, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S42-S43, 2021 | | 2021 |
| ALLOMETRIC SCALING FROM TWO-COMPARTMENT AND MPBPK MODELS OF CYNOMOLGUS MONKEY PK WERE EQUALLY PREDICTIVE OF HEALTHY HUMAN PK OF AN IGG4 MONOCLONAL ANTI-BODY. E Cobbina, T Yuraszeck, Y Cao, Y Zhang, S Liva, D Pawaskar, A Beyerle, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S61-S61, 2020 | | 2020 |
| Development of Bayesian and Non-Bayesian Melphalan Pharmacokinetic Model from Literature-Generated Data E Cobbina University of Rhode Island, 2019 | | 2019 |
| In Vitro Drug Metabolism and Population Pharmacokinetics as Tools for Elucidating Pharmacokinetic Variability E Cobbina University of Rhode Island, 2018 | | 2018 |
| Alteration in the intrinsic clearance of CYP2B6 by NAFLD: Evidence of the involvement of the metabolic syndrome in variable drug response E Cobbina, A Saravanakumar, F Akhlaghi Drug Metabolism and Pharmacokinetics 33 (1), S81, 2018 | | 2018 |
| National Rates Of 30-Day Hospital Readmissions For Adults With Asthma Exacerbation A Goizueta, E Cobbina, R Cholankeril, L Gonzalez, R El-Bizri B25. ASTHMA EPIDEMIOLOGY: EXACERBATIONS, ADMISSIONS, READMISSIONS, AND ED …, 2017 | | 2017 |
| Enlace de Complejos de Oxovanadio (IV) con Albúminas Séricas de Sangre E Cobbina, S Mehtab, I Correia, G Gonçalves, I Tomaz, I Cavaco, ... | | 2013 |
